Sample BPA Call Order - Attachment 2.xlsx

XLSX spreadsheet 14 KB Posted

Attached to
Evaluation of Abuse Potential of Synthetic Cannabinoids and Phytocannabinoids Using In Vivo Pharmacological Studies
Solicitation number
15DDHQ25Q00000010
Issued by

About this file

This document is a Sample BPA Call Order for the Drug Enforcement Administration (DEA) related to the evaluation of abuse potential of synthetic opioids and other depressants through in vivo pharmacological studies. The attachment outlines a detailed pricing template for Ordering Period 1, requiring contractors to propose a single loaded rate per Contract Line Item Number (CLIN) that includes direct labor, overhead, fringe, G&A expenses, and profit.

The call order covers 11 line items spanning various assay types, including Locomotor Activity Assays, Antagonist Studies, Drug Discrimination studies (initial training and monthly maintenance), and drug costs. The document specifies that proposals must include pricing on an "all or none basis" and that proposed fixed rates must be identical across documents. The total drug requirement involves 15 test drugs and 2 reference drugs (17 total), with a not-to-exceed drug cost of $8,500.00. Contractors are required to submit this completed Sample BPA Call Order with their Cost Proposal, verifying calculated totals per labor category and for all years.

View the file

Other files

File Type Posted
15DDHQ25Q00000010 Amendment 0001 03192025.pdf PDF
Pricing Sheet Templalte.xlsx XLSX spreadsheet
RFQ 15DDHQ25Q00000010.pdf PDF
PRICING SHEET TEMPLATE - Attachment 1.xlsx XLSX spreadsheet

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Attachment 2 - Sample BPA Call

ATTACHMENT 2: SAMPLE BPA CALL ORDER

The purpose of this BPA Call Order is to provide contractors DEA’s projected annual estimates to be ordered against the BPA.

(FOR PRICING PURPOSES ONLY)

Proposals that do not include pricing in the Sample BPA Call Order in its entirety (“all or none basis”) will not be reviewed by the government.

The completed Sample BPA Call Order shall be submitted with the contractor’s Cost Proposal. The proposed fixed rates from the Sample BPA Call Order shall be identical to the proposed fixed rate in the Pricing Sheet. Contractors shall provide a sample Call Order for Ordering Period 1 only.

The contractor shall propose a single loaded rate per Contract Line Item Number (CLIN) that includes direct labor, overhead, fringe, general and administrative expenses (G&A), and profit. The contractor must verify the calculated totals per labor category, by year, and the grand total for all years.

Title: Evaluation of Abuse Potential of Synthetic Opioids and Other Depressants Using In Vivo Pharmacological Studies

Agency:Drug Enforcement Administration
ORDERING PERIOD 1
CLIN Line ItemAssayQuantityUnitUnit PriceEstimated Total Price
1Locomotor Activity Assay Cost1
LOT
2Locomotor Activity Assay Incidental Cost1
LOT
3Antagonist Studies Assay Cost1
LOT
4Antagonist Incidental Cost1
LOT
5Drug Discrimination for initial training1
LOT
6Drug Discrimination for initial training Incidental Cost1
LOT
7Drug Discrimination (monthly maintenance of training drug) Assay Cost1
LOT
8Drug Discrimination (monthly maintenance of training drug) Incidental Cost1
LOT
9Drug Discrimination of test drug Assay Cost1LOT
10Drug Discrimination of test drug Incidental Cost1LOT
11Drug Cost Not to Exceed1LOT$500.00$8,500.00
TOTAL COST ($)
** NOTE: 15 Test Drugs + 2 Reference Drugs = 17 TOTAL DRUGS

File details come from the government source that posted it. Updated .